F2 and COVID-19: Coagulation characters in COVID-19 patients have been examined since then, where increased levels of D-dimer, fibrin degradation product, prolonged prothrombin time (PT) and activated partial thromboplastin time (aPTT) were associated with the worsened condition in COVID-19 patients [11].